DL
Publicaties op Oncologisch.com
FDA Approval Summary: Niraparib plus Abiraterone Acetate Fixed-Dose Combination for BRCA-Mutated Metastatic Castratio...
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma.
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma.
FDA-goedkeuring van talazoparib plus enzalutamide bij mCRPC
FDA-goedkeuring van lutetium-177-vipivotide tetraxetan bij mCRPC